Background: Kidney transplantation using organs from executed prisoners is a subject of controversy from the viewpoint of ethics. However, few reports have addressed the clinical outcome beyond the ethical issue. Methods: Between January 1990 and September 2004, a total of 435 kidney transplant recipients (group M) who underwent transplantation in 26 different hospitals in China were followed up at our hospital. It is believed that all the organs came from executed prisoners. The clinical data were retrieved and compared to those of 200 kidney transplant recipients (group T) who underwent transplantation in our hospital during the same period. Results: There was no significant difference between these 2 groups (T vs. M) in terms of hepatitis B virus infection (10.5% vs. 12.1%) or surgical complication rate (6.5% vs. 5.6%). The 1 st -year acute rejection rate was significantly lower in group M (31.1% vs. 24.5%, p = 0.015). The 1-year, 5-year, and 10-year patient survival rates were 94.3%, 89.5%, and 85.2%, respectively, for group T and 92.6%, 83.6%, and 76.7%, respectively, for group M (p > 0.05); the corresponding graft survival rates were 91.4%, 82.6%, and 66.9%, respectively, for group T and 91.6%, 80.0%, and 61.4%, respectively, for group M (p > 0.05). When patients were stratified according to the year of transplantation, patients who underwent transplantation between 2000 and 2004 had significantly better graft survival rates in both groups. Conclusion: We conclude that kidney transplantation using organs from executed prisoners had a clinical outcome similar to that of transplantation performed in our hospital during the same period. [J Chin Med Assoc 2007;70(5):193-199] 
Introduction
Kidney transplantation is the treatment of choice for most patients with end-stage renal disease (ESRD). However, organ shortage remains a serious problem worldwide in meeting the ever-increasing demand for organs. In Taiwan, renal transplantation has been a wellestablished surgical procedure since 1968. However, the transplant rate has been low in ESRD patients and fewer than 200 cadaveric renal transplantations are performed each year (Lee, Annual meeting of the Taiwan Society of Nephrology, 2003), which represents < 3% of the patients on the waiting list. Despite the enthusiastic promotion of living-related and living-unrelated kidney transplantation via education and public media advertisement, the transplantation rate is still low compared to that of other developed countries. 1 Owing to these circumstances, many Taiwanese have sought alternative ways to obtain organs; the most popular way is to undergo kidney transplantation in Mainland China, where using organs from executed prisoners is not prohibited. 2 From the standpoint of ethics, the use of organs from executed prisoners should be condemned, at least according to Western nations. However, controversy has been raised 3, 4 and there is no easy answer to this question. Moreover, few papers have addressed the clinical aspects beyond the ethical issues 5, 6 and most of the reports are either out of date or incomplete. There is an urgent need for information concerning organ transplantations in Mainland China using organs
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K.H. Shu, et al from executed prisoners. In this report, we present clinical data based on our experience over the past 15 years while avoiding the discussion of ethical issues.
Methods
Between January 1990 and September 2004, a total of 435 kidney transplantations were performed in Mainland China with post-transplant follow-up in our hospital (group M). This was compared with kidney transplants performed in our hospital during the same period (group T, n = 200). Kidney transplants for patients in group M were performed at 26 different hospitals around China but most of them were performed in Canton Province, which is located in southern China close to Hong Kong. Most of the patients in group M returned to Taiwan within 1-4 weeks postoperatively and were subsequently followed up by our faculty, who also took care of patients in group T. The post-transplant immunosuppressive regimens were similar in both groups and were composed of triple therapy, including corticosteroid, calcineurin inhibitor (cyclosporine or tacrolimus) and anti-metabolite (azathioprine or mycophenolate mofetil [MMF] ). After 1999, most of the patients in both groups also received anti-CD25 induction therapy (baxillisimab 20 mg on day 0 and day 4 or daclizumab 50 mg on day 0 and day 14). Before 1994, human leukocyte antigen (HLA) tissue typing was not performed routinely in group M patients, and only incomplete data were subsequently obtained. Pretransplant evaluations were sometimes incomplete in group M because many patients decided to undergo transplantation without notifying us. In group T, tissue typing as well as thorough evaluations were routinely performed pre-transplant. The selection of recipients in group T was mainly based on the extent of HLA matching and other factors such as age, status of hepatitis virus infection and comorbidity. Acute rejection was diagnosed based on clinical data and in most of the cases further supported by a graft biopsy. Anti-rejection therapy was begun with methylprednisolone pulse, 0.5 g intravenously for 3 consecutive days and if it failed, was followed by anti-lymphocyte globulin at a dose of 10 mg/kg/day or thymoglobulin at a dose of 1.5-2.5 mg/kg/day for 7-10 days.
Statistical analysis
Data were expressed as mean and standard deviation unless otherwise specified. Transplantation using organs from executed prisoners of pre-transplant hepatitis B virus (HBV) infection was similar in both groups, but the prevalence of hepatitis C virus (HCV) infection was significantly lower in group M (10.2% vs. 18.3%, p = 0.02). The mean number of mismatches in group T was 2.1 ± 0.8 for HLA-AB and 0.8 ± 0.6 for HLA-DR. More patients from group M received tacrolimus and MMF. There was no significant difference in the prevalence of pre-transplant diabetes mellitus. Table 2 and Figure 1 show the comparison of patient and graft survival rates between the 2 groups. The 1-year, 5-year, and 10-year patient survival rates were 94.3%, 89.5%, and 85.2%, respectively, for group T and 92.6%, 85.4%, and 76.7%, respectively for group M (p > 0.05), whereas the corresponding graft survival rates were 91.4%, 82.6%, and 66.9%, respectively for group T and 91.6%, 80.0%, and 61.4%, respectively for group M (p > 0.05). Table 3 Table 4 depicts the complications following renal transplantation. No significant difference was found in terms of surgical complication, post-transplant diabetes mellitus (PTDM) or malignancy. A significantly lower acute rejection rate was found in group M during the 1 st year post-transplant (24.5 vs. 31.1%, p = 0.015). Table 5 shows the causes of K.H. Shu, et al patient mortality. A remarkable proportion of deaths occurred outside our hospital and definite diagnoses were not available. Since cardiovascular complications are the leading cause of death in uremic patients and may persist even after kidney transplantation, 7 it was assumed that most of these deaths were of cardiac origin. For the known causes, infection ranked first, followed by malignancy and hepatic failure. For each cause of death, there was no statistically significant difference between groups T and M.
Discussion
The present study showed that kidney transplantations performed in Mainland China using organs from executed prisoners had results and complication rates comparable to those performed in Taiwan. To the best of our knowledge, this is the largest series to date concerning renal transplantation using organs from executed prisoners. The prevailing negative altitude toward the use of organs from executed prisoners may account for the rarity of such reports. Despite education and warning from physicians and public media about the risk and ethical issues involved, uremic patients continue to go to Mainland China for transplantation because of the severe shortage of organs in Taiwan. According to the USRDS annual report, 1 Taiwan ranks first in the incidence and second in the prevalence of ESRD in the world. The waiting list for renal transplantation in Taiwan is rapidly growing and now exceeds 6,700, whereas the total number of cadaveric kidney transplantations islandwide has remained relatively stable at around 200 cases each year for many years. Hence, academic and safety information concerning renal transplantation in China, beyond the ethical issue, is urgently needed.
The older age of group M patients simply reflects the fact that aged uremic patients are less likely to be selected for transplantation in Taiwan. The significantly shorter duration of pre-transplant dialysis in group M (median: 13.2 vs. 29.4 months; p < 0.001) was largely due to a substantial proportion of recipients receiving no dialysis at all before the surgery, i.e. preemptive transplantation, which is impossible to be listed for cadaveric renal transplantation in Taiwan. In group M, most of the transplants performed before 1994 were not matched for HLA tissue typing. Poor HLA-matched kidney transplantation is supposedly associated with increased susceptibility to acute rejection and inferior graft survival. 8 Also, older age was associated with increased risk of graft failure according to a previous report from the UK. 9 Unexpectedly, our series showed that group M had a significantly lower 1 st -year acute rejection rate (Table 4 , 24.5% vs. 31.1%; p = 0.015). It is possible that HLA matching might actually have been performed after 1994 in some of the transplant centers in Mainland China, although we were not able to obtain the data. Moreover, a diminishing effect of HLA matching on kidney survival has been demonstrated in a recent study. 10 Based on a large scale cohort study of kidney transplants registered with UNOS, the authors found that after 1998, only '6-antigen mismatches' significantly increased the hazard of graft loss. 10 Moreover, preemptive renal transplantation has been noted to be associated with better graft survival. 11, 12 In another study, a shorter duration of pre-transplant dialysis was associated with better patient and graft survival. 13 These results may partly explain why group M had a survival rate comparable to that of group T (Table 2 and Figure 1) . Furthermore, based on personal preference, and probably other unknown reasons, transplant physicians in Mainland China tend to more frequently prescribe tacrolimus as compared to cyclosporine and MMF as compared to azathioprine (Table 1 ). Both drugs have been demonstrated to be associated with a lower incidence of acute rejection 14, 15 and thus may have further contributed to a satisfactory graft and patient survival rate in group M. The analysis of survival data stratified by 3 different periods when kidney transplantations were performed further supports the assumption (Table 3 , Figures 2 and 3) . Although all the patients in group T were HLA-matched as well as possible, a significantly better graft survival rate was obtained in subgroup T-3, whose transplantations were performed between 2000 and 2004 as compared to patients who received transplantations in the earlier periods ( Figure 2 ). In our hospital, the years when newer agents were introduced for clinical transplantation were: tacrolimus 1997, MMF 1998 and anti-CD25 1999. The routine use of anti-CD25 and the increase in the number of transplant patients immunosuppressed with tacrolimus and MMF after 1999 in both groups T and M resulted in a remarkable reduction in the acute rejection rate in our study. We speculate that this is the major reason why the graft survival rate improved after 2000 in both groups (T-3 and M-3). A recent US study also reported a steady improvement in patient and graft survival rates over the past 9 years (1988-1996) . 16 Previous studies 5 have addressed the issue of hepatitis infection acquired during transplantation in Mainland China, which constituted a major cause of death among this population. Our series did not show a similar finding, although a substantial proportion of patients were infected with either HBV or HCV before going to Mainland China for transplantation (Table 1) . Taiwan used to be an endemic area for HBV infection. A survey performed in 1980 showed that over 90% of the general population under the age of 40 has been infected by HBV and 15-20% of these were chronic carriers, while the HBV-naïve population was < 10%. 17 The prevalence of HBV infection in our patients was 10.5% in group T and 12.1% in group M (Table 1) . These figures were very close to those obtained in 1981. 17 With the launch of a nationwide vaccination program since 1984, the prevalence of HBV infection has been diminishing. 18, 19 In a recent survey, seropositivity for anti-HBc, which represents the prevalence of HBV infection, was found in 2.9% of persons < 15 years of age and in 20.6% of persons aged 15-20 years. In the same age groups, the rates of anti-HBs seropositivity were 75.8% and 70.7%, respectively. 18 Based on these figures and the mean age at transplantation in our patients being 36.3 and 45.0 years in group T and group M, respectively, we assumed that the HBV-naïve population in our series was below 10%. Because it is this subpopulation that is most vulnerable to HBV infection, it may explain why HBV infection acquired in Mainland China during transplantation was not a serious complication in our series. Furthermore, based on our previous successful experience with the treatment of fulminating hepatitis B with lamivudine, 20 we routinely gave lamivudine to HBV-positive recipients as a preemptive therapy for at least 2 years post-transplant. As for active HCV infection, an ultralow dose interferon-α and ribavirin were given for at least 1 year in a few patients with reasonably good results and safety profile. 21 This management might have partly ameliorated the impact of viral hepatitis on the patient and graft survival. In fact, there was no statistically significant difference in the percentage of mortality due to hepatic failure between groups T and M (Table 5) .
Malignancy is a major complication following renal transplantation and the incidence was 6.2% in our previous report. 22 In the present study, group M patients had a higher incidence of malignancy compared to group T patients, although it did not reach statistical significance (Table 4 , 7.9% vs. 5.0%, p > 0.05). Because group M had a shorter duration of follow-up (Table 1) , it remains to be seen if a longer term of follow-up would result in a significant higher incidence of malignancy in this group.
While this study revealed an outcome of renal transplantation comparable to that in Taiwan, caution should be taken in the interpretation of the data. Group M enrolled only patients who came back from China, usually with functioning grafts. Hence, mortality that occurred shortly after transplantation was not counted. Additionally, patients with primary nonfunction post-transplantation did not always return to our hospital and were most likely followed up by the primary care nephrologists who also administered their dialysis therapy. Therefore, these patients were not counted in the present study. Taking these factors into account, the present report may have overestimated the survival rates in group M.
Finally and most importantly, the good transplantation results using organs from executed prisoners should not be used to justify this kind of surgery. Currently, our policy is to discourage ESRD patients from undergoing kidney transplantations in Mainland China. However, these patients are usually determined to undergo such transplantations and consequently do not notify us until they come back from China.
In conclusion, we have shown that renal transplantation using organs from executed prisoners had a reasonably good outcome when compared with transplantations in Taiwan. The outcome has been even better in the past 5 years, which may reflect the development of new transplantation medicine and better care of the recipients. While the ethical issue remains a major concern, quality care of these recipients should not be abandoned and clearly, a more precise analysis including early failures should be carried out in the future.
